GeDP PHARMA SRL
0.1 FTEGeDP PHARMA reported total assets of €1.69m at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Jun 2026), with 0.1 full-time equivalent.
The score of GeDP PHARMA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +261 % Total assets +255 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
GeDP PHARMA's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
- Year ended 31 Dec 2024filed on 13 Jun 2025
- Year ended 31 Dec 2023filed on 30 Jun 2024
GeDP PHARMA's financial analysis
- Solvency4.3%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of GeDP PHARMA
GeDP PHARMA's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0802.649.363
- VAT number
- BE0802649363
- Peppol
- Registered · 0208:0802649363 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Jun 2023
- Registered office
- 8300 Knokke-Heist
- Size
- Micro · 0.1 FTE
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
GeDP PHARMA (SRL) has been based in Knokke-Heist since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 36,166 € and equity of 73,280 €; its revenue is not published. With 0.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 4.3%, below the median of its sector (44.0%).
Companies similar to GeDP PHARMA
Companies in the same business, of comparable size and area, outside its group.
- Antoine Pharma Retail sale of pharmaceutical products Ixelles · balance sheet €1.46m
- Digitale Retail sale of pharmaceutical products Etterbeek · balance sheet €1.38m
- Pharmacie Herbint Retail sale of pharmaceutical products Evere · balance sheet €1.83m
- Pharmakes Retail sale of pharmaceutical products Ypres · balance sheet €1.57m
- Cardoen Pharma Retail sale of pharmaceutical products Wingene · balance sheet €1.79m
- Saarbach Dino Retail sale of pharmaceutical products Chaudfontaine · balance sheet €1.44m
- Apharmat Retail sale of pharmaceutical products Antwerp · balance sheet €1.42m
- Duchi-Naert Retail sale of pharmaceutical products Harelbeke · balance sheet €1.52m
Frequently asked questions about GeDP PHARMA
What is the revenue of GeDP PHARMA?
GeDP PHARMA files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of GeDP PHARMA?
In Belgium, the VAT number is the company number prefixed with BE: BE0802649363 for GeDP PHARMA, if the company is VAT-registered. Its company number (CBE) is 0802.649.363.
Where is the registered office of GeDP PHARMA?
According to the CBE register, the registered office of GeDP PHARMA is in 8300 Knokke-Heist.
What is the equity of GeDP PHARMA?
At the close of the 2025 financial year, the equity of GeDP PHARMA amounts to 73,280 €, a solvency of 4.3% of total assets.
How many people work at GeDP PHARMA?
0.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages GeDP PHARMA?
The register lists 1 active mandates at GeDP PHARMA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of GeDP PHARMA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →